56
13
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40423 |
L48H37
|
||
L48H37是Curcumin的一个化学稳定类似物。它对髓系分化蛋白2 (MD2) 表现出强效的抑制性质,作为一个特异性抑制剂。其机制包括抑制LPS-TLR4/MD2的相互作用和信号传导。L48H37主要用于脓血症和肺损伤研究[1]。 | |||
T10831L |
Cl-amidine hydrochloride
|
Apoptosis; PAD | Apoptosis; Chromatin/Epigenetic |
Cl-amidine hydrochloride 是一种口服有效的PAD 抑制剂,可阻断组蛋白 3 瓜氨酸化和中性粒细胞胞外陷阱的形成,并提高败血症小鼠的存活率。它可诱导癌细胞凋亡,还可诱导 miR-16 引起细胞周期阻滞。 | |||
T4989 |
Fosfomycin Tromethamine
|
Antibacterial; Antibiotic | Microbiology/Virology |
Fosfomycin tromethamine 是一种能透过血脑屏障的广谱抗生素,不可逆地抑制细胞壁合成的早期阶段。它对多种细菌具有杀菌活性,包括耐多药、广泛耐药和耐全药细菌。 | |||
T1001 |
Dicloxacillin Sodium hydrate
Dicloxacillin sodium salt monohydrate,双氯西林钠,Dicloxacillin sodium monohydrate |
Antibacterial; Antibiotic | Microbiology/Virology |
Dicloxacillin Sodium hydrate 是一种青霉素类窄谱β内酰胺抗生素,可研究革兰氏阳性菌感染。 | |||
T3131 |
Fosfomycin calcium
Phosphomycin calcium salt,Fosmicin,磷霉素钙 |
Antibacterial; Antibiotic | Microbiology/Virology |
Fosfomycin calcium (Phosphomycin calcium salt) 是一种能透过血脑屏障的广谱抗生素,不可逆地抑制细胞壁合成的早期阶段。它对多种细菌具有杀菌活性,包括耐多药、广泛耐药和耐全药细菌。 | |||
T12242 |
Norvancomycin hydrochloride
Desmethyl-vancomycin hydrochloride,盐酸去甲万古霉素 |
Antibacterial | Microbiology/Virology |
Norvancomycin hydrochloride (Desmethyl-vancomycin hydrochloride) 可用于葡萄球菌所致的心内膜炎、骨髓炎、肺炎、败血症或软组织感染。 | |||
T9543 |
Syk Inhibitor II hydrochloride
|
Others | Others |
Syk Inhibitor II hydrochloride 信号传导的影响在狼疮中可能很突出。 | |||
T8134 |
Cefathiamidine
|
Antibacterial; Antibiotic | Microbiology/Virology |
Cefathiamidine 是一种头孢菌素抗菌剂,可研究由易感细菌引起的感染,还可用于呼吸道、肝脏、五官感觉、尿路感染以及心内膜炎和败血症的研究。 | |||
T66175 |
Ceftriaxone Sodium
|
GSK-3; Antibiotic; Aurora Kinase | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Microbiology/Virology; PI3K/Akt/mTOR signaling; Stem Cells |
Ceftriaxone Sodium 是一种广谱 β-内酰胺类三代头孢菌素类抗生素 (antibiotic),具有抗炎、抗肿瘤、抗菌和抗氧化活性。Ceftriaxone Sodium 是一种共价 GSK3β和 Aurora B 抑制剂, 可用于研究败血症和感染性心内膜炎。 | |||
T67965 |
Torbafylline
|
cAMP; PI3K; PDE | GPCR/G Protein; Metabolism; PI3K/Akt/mTOR signaling |
Torbafylline 是黄嘌呤衍生物,是 磷酸二酯酶 (PDE) 抑制剂,通过 激活 PDE4/cAMP/EPAC/PI3K/Akt 途径减弱烧伤诱导的大鼠骨骼肌蛋白水解,抑制癌症和败血症大鼠增强的骨骼肌泛素 - 蛋白酶体依赖性蛋白水解。 | |||
T76662 |
Ac-Pro-Gly-Pro-OH
|
Apoptosis; CXCR; Antibiotic | Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology |
Ac-Pro-Gly-Pro-OH 是乙酰基修饰的三肽化合物,可用作 CXCR2 激动剂。Ac-Pro-Gly-Pro-OH 具有杀菌和抗炎活性,抑制免疫细胞凋亡,抑制促炎细胞因子的产生。Ac-Pro-Gly-Pro-OH 可用于研究脓毒症和肺部炎症。 | |||
TP1570 |
Cortistatin-14
|
Somatostatin | GPCR/G Protein |
Cortistatin-14 是一种与生长抑素-14结构相似的神经肽,具有抗惊厥和神经保护作用,通过激活 sst(2)、生长素释放肽和 GABA(A/B) 受体损害小鼠的识别记忆巩固,可用于研究脓毒症引发的认知障碍。 | |||
T74398 |
DATPT
|
Reactive Oxygen Species; Antibacterial | Immunology/Inflammation; Metabolism; Microbiology/Virology; NF-κB |
DATPT 是一种小分子 12WLVSKF17 肽模拟分子。DATPT 抑制 SNX9-p47phox 相互作用,抑制活性氧和炎性细胞因子的产生。DATPT 具有抗炎和抗菌活性,通过减少 ATP 的产生发挥作用。DATPT 是治疗脓毒症的潜在化合物。 | |||
T74485 |
STC314
|
Others | Others |
STC314 具有抗感染作用,通过中和胞外组蛋白和中性粒细胞诱捕网来逆转机体过度免疫反应造成的器官损伤,可用于研究脓毒症和急性呼吸窘迫综合征(ARDS)。STC314 可保护脂质双层的稳定性,抑制血小板活化和红细胞损伤。 | |||
T77097 | Nerelimomab | ||
Nerelimomab (BAYX1351) 是一种抗TNF-α抗体。Nerelimomab 可用于脓毒症研究。 | |||
T40225 |
JH-X-119-01 hydrochloride
|
||
JH-X-119-01 hydrochloride is a potent and selective inhibitor of interleukin-1 receptor-associated kinases 1 (IRAK1). It effectively alleviates lipopolysaccharide (LPS)-induced sepsis in mice. | |||
T60563 | NLRP3/AIM2-IN-1 | ||
NLRP3/AIM2-IN-1是热脓毒症的抑制剂(IC50 = 3.136 ± 0.7667 μM),显示出适度的反热光活性。 | |||
T70480 |
FPL-65447 hydrochloride
|
||
FPL-65447 hydrochloride is a selective D1 receptor agonist that has potential for the acute treatment of renal and cardiac failure and of sepsis and septic shock. | |||
T61957 |
Aldose reductase-IN-3
|
||
Aldose reductase-IN-3 (Compound 5) 是有效的、中等选择性的醛糖还原酶 (AR) 抑制剂(IC50= 3.99 μM)。醛糖还原酶是参与各种炎症性疾病 (包括败血症) 的分子靶标。Aldose reductase-IN-3在脓毒症中具有研究的潜力。 | |||
T62275 | BET-IN-8 | ||
BET-IN-8 (Compound 27) 是一种 BET 的有效抑制剂 (Ki: 0.83 μM, Kd: 0.571 μM)。BET-IN-8 能够改善体内 LPS 诱导的脓毒症。BET-IN-8 对脓毒症表现出研究潜力。 | |||
T77095 | Nebacumab | ||
Nebacumab (HA-1A)为一种与内毒素的脂质A部分结合的单克隆抗体,适用于败血症研究。 | |||
T70874 |
Vipoglanstat
|
||
Vipoglanstat is a prostaglandin E synthase inhibitor and an anti-inflammatory. Vipoglanstat ameliorates leukocyte infiltration and lung injury resulting from both endotoxin-induced and sepsis-induced lung injury. | |||
T39009 |
CAP18 (rabbit)
CAP18 (rabbit) |
||
CAP18 (rabbit) is a 37 amino acid antimicrobial peptide derived from rabbit granulocytes. It exhibits extensive antimicrobial activity against both Gram-positive (IC50, 130-200 nM) and Gram-negative (IC50, 20-100 nM) bacteria. Thus, CAP18 (rabbit) holds promise for the study and advancement of bacterial sepsis research. | |||
T61253 |
BET-IN-7
|
||
BET-IN-7 (Compound 1) is a highly effective BET inhibitor, possessing a K i of 12.27 μM and a K d of 89.3 μM. It exhibits promising properties for sepsis-related research [1]. | |||
T74179 |
1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine
|
||
1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine,一种血液中的内源性代谢物,主要用于妊娠和败血症的研究。 | |||
T70268 |
3A-MPLA
|
||
Monophosphoryl lipid A (MPLA) is a natural agonist for the toll-like receptor-4 (TLR4). It is useful as an adjuvant in immunization. MPLA is a safe prophylactic agent and has immunotherapeutic applications. It induces tumor necrosis factor and interleukin (IL)-1β, however not as efficient as lipopolysaccharide (LPS). MPLA improves immune response during bacterial sepsis infection. | |||
T80535 |
AMPR-22
|
||
AMPR-22 是一种具有抗菌作用的肽类化合物,能够与细菌膜结合并诱导透化作用,对 MDR 菌株引起的败血症小鼠模型表现出有效的对抗性。 | |||
T79790 |
ALPK1-IN-3
|
NF-κB | NF-κB |
ALPK1-IN-3 (T007)为ALPK1抑制剂。在脓毒症引起的急性肾损伤动物模型中,ALPK1-IN-3能够降低肾脏促炎基因的表达并增加动物的存活率。 | |||
T63660 |
Anti-inflammatory agent 19
|
||
Anti-inflammatory agent 19 能够抑制 NO (IC50: 36.00 μM)。Anti-inflammatory agent 19 对 HMGB1 诱导的后期炎症反应表现出抑制作用。Anti-inflammatory agent 19 能够用于研究后期炎症疾病,如冠状病毒病 (COVID-19)、败血症等。 | |||
T78561 | M62812 free base | ||
M62812 (free base) 是一种TLR4信号转导抑制剂,能够抑制内皮细胞和白细胞的活化,有效预防小鼠致死性感染性休克,适用于脓毒症的研究。 | |||
T76902 | Afelimomab | ||
Afelimomab (MAK 195F)为F(ab')2型单克隆抗体片段,针对肿瘤坏死因子抗体,应用于脓毒症研究。 | |||
T82505 |
Edobacomab
XMMEN-0E5,E5 |
||
Edobacomab (E5) 是小鼠来源的抗内毒素单克隆IgM抗体,常用于研究由革兰氏阴性细菌引起的败血症。 | |||
T76822 | Pagibaximab | ||
Pagibaximab为一种嵌合IgG1抗体,针对金黄色葡萄球菌与表皮链球菌的表面脂肪酸成分具有特异性识别能力。其主要应用于预防葡萄球菌所引起的败血症。 | |||
T70145 |
LYRM03
|
||
LYRM03 is an aminopeptidase inhibitor. LYRM03 is also an ubenimex derivative. LYRM03 attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway. LYRM03 effectively attenuates LPS-induced ALI by inhibiting the expression of pro-inflammatory mediators and Myd88-dependent TLR4 signaling pathways in alveolar macrophages. LYRM03 may serve as a potential treatment for sepsis-mediated lung injuries. | |||
T80062 |
Mitogen-activated protein kinase 1
MAPK1 |
NF-κB | NF-κB |
Mitogen-activated protein kinase1 (MAPK1) 能够激活下游的 p38/NF-κB 通路,并调控多种与脓毒症相关的疾病细胞过程。此外,MAPK1 通过磷酸化催化底物蛋白,起到调节底物蛋白活性开关的作用。 | |||
T75011 | STING-IN-5 | STING | Immunology/Inflammation |
STING-IN-5为有效STING抑制剂,IC50达1.15 μM,能在巨噬细胞内抑制LSP诱导之NO合成,从而抑制炎症反应,主用于抗炎疾病与败血症研究。 | |||
T63473 | Anti-inflammatory agent 18 | ||
Anti-inflammatory agent 18 能够抑制NO 的活性 (IC50: 15.94 μM),对 HMGB1 诱导的后期炎症反应具有抑制作用,能够用于研究后期炎症疾病,如冠状病毒病 (COVID-19)、败血症等。 | |||
T81269 |
RIPK1-IN-16
|
RIP kinase | Apoptosis; NF-κB |
RIPK1-IN-16是口服活性的RIPK1抑制剂,有效阻断RIPK1介导的necroptosis,抑制炎症反应。在小鼠模型中,RIPK1-IN-16通过抵御TNF引发的全身性炎症综合症和败血症来展现保护作用。 | |||
T62229 | BBS-4 | ||
BBS-4 是一种选择性的、有效的诱导型一氧化氮合酶 (NOS2) 二聚抑制剂 (IC50: 0.49 nM),BBS-4 能够保护小鼠,使其免受败血症的心血管功能障碍的影响。 | |||
T78056 |
HMGB1-IN-1
|
||
HMGB1-IN-1(化合物6)在RAW264.7细胞中具有显著的NO抑制活性,其IC50为15.9 ± 0.6 μM。该化合物能够抑制HMGB1/NF-κB/NLRP3信号通路,并且在肾损伤模型中展现出优异的抗炎及抗脓毒症效果。 | |||
T83685 |
UFP101 TFA
|
||
UFP101是一种合成肽类物质,作为nociceptin受体的拮抗剂(Ki为0.06 nM,测试于表达人类受体的CHO细胞中)。它对nociceptin受体的选择性高于κ-opioid受体(Ki为204 nM,测试于表达大鼠受体的CHO细胞中)。UFP101能抑制表达于CHO细胞膜的nociceptin受体释放GTPγS(EC50为1.86 nM)。通过脑室内给药,UFP101(10 nmol/每只动物)能延长小鼠尾巴甩动试验中的尾巴撤回潜伏期。在由盲肠结扎和穿刺诱发的小鼠败血症模型中,UFP101(0.003、0.03及0.3 mg/kg)能提高生存率。 | |||
T76327 |
CTCE-0214
|
||
CTCE-0214 是一种 CXCR4(chemokine CXC receptor 4) 激动剂,是 SDF-1α 肽类似物。CTCE-0214 具有抗炎活性,可用于炎症败血症和系统性炎症综合征的研究。 | |||
T76958 | Vilobelimab | ||
Vilobelimab (CaCP-29, IFX-1) 是一种单克隆抗 C5a 抗体,过敏毒素 C5a 是一种促炎补体分裂产物,在介导器官功能障碍中起核心作用。Vilobelimab 可作为一种 C5a 抑制剂,抑制中性粒细胞活化、趋化性,减少炎症信号等,可用于败血症,COVID-19 等相关研究。 | |||
T82526 |
Drotrecogin alfa (activated)
|
||
Drotrecogin alfa activated (DrotAA)为重组人活化蛋白C(APC)。该化合物能够抑制由烟雾引起的大鼠肺微血管通透性上升及促炎细胞因子IL-1β水平增加,具有抗凝血与抗炎作用,并促进纤溶过程。Drotrecogin alfa activated主要用于重症脓毒症的实验研究。 | |||
T63793 | Tauro-ω-muricholic acid sodium | ||
Tauro-ω-muricholic acid sodium (TωMCA sodium) 是一种tauro-α-muricholic acid 的类似物,是来源于肝脏的胆汁酸。Tauro-ω-muricholic acid sodium 能用作早发性新生儿败血症 (EOS) 和胆汁淤积的血清标志物。 | |||
T79409 |
Antibacterial agent 154
|
||
Antibacterialagent 154(compound 7)作为Fluoroquinolones类衍生物,适用于口服的抗菌治疗。它针对革兰氏阳性菌与阴性菌具有抑制作用,并在小鼠葡萄球菌败血症模型中显示出了体内效力。 | |||
T60934 |
PDE4-IN-9
|
||
PDE4-IN-9 (Compound 5j) 是 PDE4的有效抑制剂。在体外酶学测定结果表明,PDE4-IN-9 对 PDE4 的IC50值为1.4 μM ,低于母体咯利普兰的2.0 μM。PDE4-IN-9 在 LPS 诱导的哮喘/COPD 和脓毒症动物模型中也表现出良好的体内活性。 | |||
T78829 |
JNK2-IN-1
|
JNK | MAPK |
JNK2-IN-1(Compound J27)是一款具有抗炎活性的JNK2抑制剂,其解离常数为79.2 μM。该化合物能通过阻断NF-κB/MAPK信号通路来降低肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)的释放,从而减轻脂多糖(LPS)引起的急性肺损伤(ALI)及脓毒症症状。 | |||
T81579 |
P2X7 receptor antagonist-4
|
||
P2X7 receptor antagonist-4(Compound 14a)是一种选择性P2X7R拮抗剂,其对人类和小鼠P2X7R的IC50值分别为64.7 nM和10.1 nM。该化合物能有效抑制NLRP3炎性体的激活,并在脓毒症模型小鼠中减少肾损伤,降低caspase-1、gasdermin D、IL-1β和IL-18的表达。 | |||
T71984 |
Enrofloxacin-d5
|
||
Enrofloxacin-d5 is intended for use as an internal standard for the quantification of enrofloxacin by GC- or LC-MS. Enrofloxacin is a fluoroquinolone antibiotic. It is active against panels of Campylobacter, E. coli, and Salmonella isolates (mean MIC50s = 0.06, 0.5, and 0.03 µg/ml, respectively). It is also active against equine isolates of L. intracellularis (MICs = 0.125-0.5 µg/ml). Enrofloxacin inhibits bacterial DNA gyrase. In vivo, enrofloxacin (10 mg/kg) increases survival in a mouse model... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN1039 |
Tamarixetin
柽柳黄素,4'-O-Methyl Quercetin |
Endogenous Metabolite; Immunology/Inflammation related | Immunology/Inflammation; Metabolism |
Tamarixetin (4'-O-Methyl Quercetin) 是一种槲皮素的天然类黄酮衍生物,具有抗氧化、抗炎作用,能够防止心肌肥厚。 | |||
T1221 |
Acetylcholine chloride
ACh chloride,Pilofrin,氯化乙酰胆碱 |
Calcium Channel; Endogenous Metabolite; AChR | Membrane transporter/Ion channel; Metabolism; Neuroscience |
Acetylcholine chloride (Pilofrin) 是一种神经递质,是胆碱能激动剂,通过刺激烟碱乙酰胆碱受体调节多巴胺能神经元活性,在体外抑制 p53 突变肽的聚集。 | |||
T8262 |
Fosfomycin sodium
Fosfomycin Disodium,磷霉素钠 |
Antibacterial; Antibiotic | Microbiology/Virology |
Fosfomycin sodium 是一种能透过血脑屏障的广谱抗生素,不可逆地抑制细胞壁合成的早期阶段。它对多种细菌具有杀菌活性,包括耐多药、广泛耐药和耐全药的细菌。 | |||
TN6926 |
Paeonoside
|
Others | Others |
Paeonoside 发现与P. suffruticosa 中,具有生物活性,可以促进成骨细胞分化过程中的伤口愈合和迁移。Paeonoside 具有一定的抗糖尿病活性,可防止脓毒症和败血症引起的死亡。Paeonoside 对 MC3T3-E1细胞的前成骨细胞没有细胞毒性作用,以剂量依赖性的方式显著恢复伤口区域并促进细胞迁移和促进碱性磷酸酶(ALP)染色及其活性。 | |||
TN1594 |
DL-Syringaresinol
(±)-Syringaresinol |
Antioxidant; Antifungal | Microbiology/Virology; oxidation-reduction |
DL-Syringaresinol ( (±)-Syringaresinol) 是一种来自与人参浆果的木质素,具有抗炎、抗氧化、镇痛活性和较弱的抗分枝杆菌活性。DL-Syringaresinol 可通过自噬延缓氧化应激诱导的皮肤老化,通过抑制炎症反应来缓解奥沙利铂诱导的神经性疼痛和脓毒症引起的心功能障碍。 | |||
TN6774 |
Emodin 6-O-β-D-glucoside
大黄素-6-O-β-D-葡萄糖苷,Glucoemodin |
Others | Others |
Emodin 6-O-β-D-glucoside (Glucoemodin) 是一种从 Reynoutria japonica 中提取的活性化合物。它具有显著的抗炎和屏障保护活性,可用于研究动脉粥样硬化及糖尿病并发症。 | |||
T5S0167 |
Atractylenolide I
白术内酯 I,白术内酯I;苍术内酯I |
IL Receptor; TNF; TLR; JAK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; Immunology/Inflammation; JAK/STAT signaling; Stem Cells |
Atractylenolide I 是从白术根中得到的一种倍半萜烯,具有神经保护、抗过敏、抗炎和抗癌等多种生物活性。它是一种TLR4拮抗剂,在 A375 细胞中,能够降低JAK2和STAT3的磷酸化水平。 | |||
T0186 |
Docetaxel trihydrate
RP-56976 (Trihydrate),RP56976 (NSC 628503) Trihydrate,多西他赛三水合物 |
Apoptosis; BCL; Microtubule Associated | Apoptosis; Cytoskeletal Signaling |
Docetaxel trihydrate (RP-56976 Trihydrate) 是一种抗肿瘤试剂,抑制微管解聚的IC50值为 0.2 μM。它是紫杉醇的半合成类似物,能减弱 bcl-2 和 bcl-xL 基因表达的影响。它阻滞G2/M 细胞周期,导致细胞凋亡。 | |||
TN4992 |
Senkyunolide G
|
Others | Others |
Senkyunolide G and senkyunolide I could serve as pharmacokinetic markers for sepsis care. | |||
TN4679 |
Nudiposide
|
IL Receptor; TNF | Apoptosis; Immunology/Inflammation |
Nudiposide has significant neuroprotective activities against glutamate-injured neurotoxicity in HT22 cells. It also exhibits protective effect against sepsis in a mouse model and can decrease the plasma levels of TNF-α, IL-10 and ALT activity. | |||
TN1374 |
α-Chaconine
alpha-Chaconine,卡茄碱,阿尔法卡茄碱 |
IL Receptor; COX; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Immunology/Inflammation; Neuroscience |
Alpha-Chaconine has anti-inflammatory effect, associated with the suppression of AP-1, and supports its possible therapeutic role for the treatment of sepsis. Alpha-Chaconine also has cytotoxic effects. | |||
TN1874 |
Liriodendrin
鹅掌楸苦素 |
ATPase; Potassium Channel; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Membrane transporter/Ion channel |
Liriodendrin 调节肺部炎症、NF-kB (p65) 的磷酸化和血管内皮生长因子 (VEGF) 的表达。Liriodendrin 具有抗炎、镇痛、降血糖活性,在脓毒症引起的急性肺损伤中起保护作用。 | |||
TN4490 | Manassantin B | ERK; BCL; p38 MAPK; TNF; NF-κB; JNK; STAT; Antifection | Apoptosis; JAK/STAT signaling; MAPK; Microbiology/Virology; NF-κB; Stem Cells |
Manassantin B is a potent inhibitor of NF-κB activation by the suppression of transciptional activity of RelA/p65 subunit of NF-κB. It also possesses anti-EBV lytic replication activity. Manassantin B inhibits interleukin-6-induced signal transducer and activator of transcription 3 activation in Hep3B cells, it has potential as a potent anti-inflammatory drug for use in pathological processes such as sepsis or acute lung injury. Manassantin B exerts antifibrotic activity in HSC-T6 cells, in pa... |